Physician profile
David M Atwell
NPI 1710936828
$445.29
in general payments reported to CMS, 2019-2025
8 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.20 · 2020: $79.44 · 2021: $40.05 · 2022: $17.89 · 2023: $45.85 · 2024: $128 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149 · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.77 |
| Education | $142.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $195.70 | 2020-2025 | |
| Baxter Healthcare | $96.89 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Jazz Pharmaceuticals INC. | $42.95 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $40.05 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.96 | 2020 | |
| Boston Scientific Corporation | $19.68 | 2023 | G4 Rf Generator |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.20 | 2019 | |
| Glaxosmithkline, LLC. | $13.86 | 2024 | Trelegy Ellipta, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Atwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.